The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Ang II–Stimulated Superoxide Production Is Mediated via Phospholipase D in Human Vascular Smooth Muscle Cells
Open accessAbstract
Abstract —Intracellular signaling events that mediate the long-term effects of Ang II in vascular smooth muscle cells are unclear, but oxidative stress may play an important role. This study examined the ability of Ang II to generate reactive oxygen species and investigated the putative role of phospholipase D (PLD)–dependent signaling pathways for its production in human vascular smooth muscle cells. In addition, we assessed whether redox-sensitive pathways influence Ang II–stimulated cell growth. Primary and low-passage cells (passages 1 to 4) derived from resistance arteries of subcutaneous gluteal biopsies from healthy subjects were studied. Oxidative stress was measured with the fluorescent probe 5-(and 6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate (CM-H 2 DCFDA) (8 μmol/L), and the role of PLD was assessed with the PLD inhibitor d - erythro -sphingosine, dihydro (sphinganine) (10 μmol/L). To determine whether NADH/NADPH oxidase contributes to production of reactive oxygen species, Ang II–stimulated cells were pretreated with the specific flavoprotein inhibitor diphenylene iodinium (DPI) (10 μmol/L). DNA and protein synthesis were determined by [ 3 H]thymidine and [ 3 H]leucine incorporation, respectively. Ang II increased CM-H 2 DCFDA fluorescence, and this was inhibited by catalase (350 U/mL), indicating that the fluorescence signal was derived predominantly from H 2 O 2 . Ang II dose-dependently increased H 2 O 2 production (E max =57.6±1.7 nmol/L, pD 2 =7.7±0.06) and PLD activation (E max =207±3.3% of control, pD 2 =7.7±0.5). H 2 O 2 effects were evident within 1 hour, and maximal PLD activation occurred within 40 minutes after stimulation. DPI inhibited ( P <0.01) Ang II–stimulated responses. PLD inhibition significantly attenuated ( P <0.05) Ang II–elicited H 2 O 2 production (E max =29±5 nmol/L). DPI and sphinganine inhibited Ang II–induced DNA and protein synthesis. These data indicate that in vascular smooth muscle cells from human peripheral resistance arteries, Ang II increases H 2 O 2 generation via PLD-dependent, NADH/NADPH oxidase–sensitive pathways. These cascades may function as second messengers in long-term Ang II–mediated growth-signaling events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Superoxide Anion Radical (O·̄2), Superoxide Dismutases, and Related Matters
Fridovich, I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18515 · Cited by 1,337
Cited by
Reactive oxygen species in cell signaling
Thannickal, V. J., & Fanburg, B. L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1005 · Cited by 2,927
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Role of oxidative stress in atherosclerosis
Harrison, D., Griendling, K. K., Landmesser, U., Hornig, B., & Drexler, H. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03144-2 · Cited by 1,275
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassègue, B., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,032
Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice
Johansen, J. S., Harris, A. K., Rychly, D. J., & Ergul, A. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-5 · Cited by 1,003
Griendling, K. K., Sorescu, D., Lassègue, B., & Ushio-Fukai, M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2175 · Cited by 955
Touyz, R. M., & Schiffrin, E. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01471-6 · Cited by 934
Self-citationRegulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance
Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005942 · Cited by 802
Angiotensin II Stimulation of NAD(P)H Oxidase Activity: Upstream Mediators
Seshiah, P. N., Weber, D. S., Rocic, P., Valppu, L., Taniyama, Y., & Griendling, K. K. (2002) · Circulation Research · doi:10.1161/01.res.0000033523.08033.16 · Cited by 709
Vascular smooth muscle contraction in hypertension
Touyz, R. M., Alves-Lopes, R., Rios, F. J., Camargo, L. L., Anagnostopoulou, A., Arner, A., & Montezano, A. C. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy023 · Cited by 697
Self-citationThe vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
Cai, H., Griendling, K. K., & Harrison, D. G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00233-5 · Cited by 687
Reactive oxygen species in vascular biology: implications in hypertension
Touyz, R. M., & Schiffrin, E. L. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0696-7 · Cited by 646
Self-citationTouyz, R. M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M. T., Pagano, P. J., & Schiffrin, E. L. (2002) · Circulation Research · doi:10.1161/01.res.0000020404.01971.2f · Cited by 590
Self-citationHunyady, L., & Catt, K. J. (2006) · Molecular Endocrinology · doi:10.1210/me.2004-0536 · Cited by 541
Oxidative stress in cell culture: an under‐appreciated problem?
Halliwell, B. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00235-7 · Cited by 534
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 534
Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature
Nguyen Dinh Cat, A., Montezano, A. C., Burger, D., & Touyz, R. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4641 · Cited by 464
Self-citationReactive oxygen species as mediators of angiotensin II signaling
Griendling, K. K., & Ushio-Fukai, M. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00136-1 · Cited by 417
Angiotensin II and Vascular Injury
Montezano, A. C., Nguyen Dinh Cat, A., Rios, F. J., & Touyz, R. M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0431-2 · Cited by 402
Self-citationSedeek, M., Callera, G., Montezano, A., Gutsol, A., Heitz, F., Szyndralewiez, C., Page, P., Kennedy, C. R. J., Burns, K. D., Touyz, R. M., et al. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00028.2010 · Cited by 396
Self-citationNADPH oxidases and angiotensin II receptor signaling
Garrido, A. M., & Griendling, K. K. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.003 · Cited by 386
Reactive oxygen species signaling in vascular smooth muscle cells
CLEMPUS, R., & GRIENDLING, K. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.033 · Cited by 358
Reactive oxygen species: Roles in blood pressure and kidney function
Wilcox, C. S. (2002) · Current Hypertension Reports · doi:10.1007/s11906-002-0041-2 · Cited by 341
Boustany, C. M., Bharadwaj, K., Daugherty, A., Brown, D. R., Randall, D. C., & Cassis, L. A. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00265.2004 · Cited by 337
Immunosuppressive Treatment Protects Against Angiotensin II-Induced Renal Damage
Muller, D. N., Shagdarsuren, E., Park, J.-K., Dechend, R., Mervaala, E., Hampich, F., Fiebeler, A., Ju, X., Finckenberg, P., Theuer, J., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64445-8 · Cited by 278
Touyz, R. M., Yao, G., & Schiffrin, E. L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000069236.27911.68 · Cited by 270
Self-citationTouyz, R. M., & Schiffrin, E. L. (2001) · Journal of Hypertension · doi:10.1097/00004872-200107000-00009 · Cited by 257
Self-citationBalakumar, P., & Jagadeesh, G. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.06.011 · Cited by 182
Metadata
- Authors
- Touyz, R. M., & Schiffrin, E. L.
- Venue
- Hypertension
- Published
- 1999-10
- Volume
- 34
- Issue
- 4
- Pages
- 976-982
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2137630689
- Cited by
- 203
- References
- 1
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.